Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

338 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Baz M, et al. Among authors: abed y. N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11. N Engl J Med. 2009. PMID: 19907034 No abstract available.
Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
Abed Y, Nehmé B, Baz M, Boivin G. Abed Y, et al. Antiviral Res. 2008 Feb;77(2):163-6. doi: 10.1016/j.antiviral.2007.08.008. Epub 2007 Sep 10. Antiviral Res. 2008. PMID: 17919743
Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in mice.
Baz M, Abed Y, Nehmé B, Boivin G. Baz M, et al. Among authors: abed y. Antimicrob Agents Chemother. 2009 Feb;53(2):791-3. doi: 10.1128/AAC.01276-08. Epub 2008 Nov 17. Antimicrob Agents Chemother. 2009. PMID: 19015327 Free PMC article.
A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
Abed Y, Baz M, Boivin G. Abed Y, et al. J Infect Dis. 2009 Jan 15;199(2):180-3. doi: 10.1086/595736. J Infect Dis. 2009. PMID: 19046066
Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
Baz M, Abed Y, Simon P, Hamelin ME, Boivin G. Baz M, et al. Among authors: abed y. J Infect Dis. 2010 Mar;201(5):740-5. doi: 10.1086/650464. J Infect Dis. 2010. PMID: 20100088
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.
Hamelin ME, Baz M, Abed Y, Couture C, Joubert P, Beaulieu E, Bellerose N, Plante M, Mallett C, Schumer G, Kobinger GP, Boivin G. Hamelin ME, et al. Among authors: abed y. PLoS Pathog. 2010 Jul 22;6(7):e1001015. doi: 10.1371/journal.ppat.1001015. PLoS Pathog. 2010. PMID: 20661429 Free PMC article.
The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant.
Simon P, Holder BP, Bouhy X, Abed Y, Beauchemin CA, Boivin G. Simon P, et al. Among authors: abed y. J Clin Microbiol. 2011 Feb;49(2):715-7. doi: 10.1128/JCM.01732-10. Epub 2010 Nov 24. J Clin Microbiol. 2011. PMID: 21106781 Free PMC article.
Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
Pizzorno A, Bouhy X, Abed Y, Boivin G. Pizzorno A, et al. Among authors: abed y. J Infect Dis. 2011 Jan 1;203(1):25-31. doi: 10.1093/infdis/jiq010. J Infect Dis. 2011. PMID: 21148493 Free PMC article.
Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model.
Holder BP, Simon P, Liao LE, Abed Y, Bouhy X, Beauchemin CA, Boivin G. Holder BP, et al. Among authors: abed y. PLoS One. 2011 Mar 24;6(3):e14767. doi: 10.1371/journal.pone.0014767. PLoS One. 2011. PMID: 21455300 Free PMC article.
Parenteral peramivir treatment for Oseltamivir-resistant 2009 pandemic influenza A H1N1 viruses.
Abed Y, Boivin G, Yoshida R, Kodama M, Hernandez JE. Abed Y, et al. J Infect Dis. 2011 Nov 15;204(10):1641-2; author's reply 1642-3. doi: 10.1093/infdis/jir610. Epub 2011 Sep 23. J Infect Dis. 2011. PMID: 21949045 No abstract available.
338 results
Jump to page